MAP18: An Open-Label, Phase 2, Multicenter Feasibility Study of Manualized MDMA-Assisted Psychotherapy with an Optional fMRI Sub-Study Assessing Changes in Brain Activity in Subjects with Posttraumatic Stress Disorder

Project: Research

Project Details

AcronymMP18
StatusActive
Effective start/end date21/03/2022 → 31/03/2026

Collaborative partners

  • King's College London (lead)
  • MAPS Public Benefit Corporation
  • SLaM South London and Maudsley NHS Foundation Trust
  • KCH King's College Hospital NHS Foundation Trust

Funding

  • Supporting Wounded Veterans: £135,263.86